ADAM28: Another ambivalent protease in cancer

Volume: 494, Pages: 18 - 26
Published: Dec 1, 2020
Abstract
Emergence of novel therapeutic options in a perspective of personalized therapy of cancer relies on the discovery of precise molecular mechanisms involved in the switch from a localized tumor to invasive metastasis spread. Pro-tumor functions have been mostly ascribed to proteolytic enzymes from the metalloproteinase family including A Disintegrin And Metalloproteinases (ADAMs). Particularly, when expressed by cancer cells, ADAM28 protease...
Paper Details
Title
ADAM28: Another ambivalent protease in cancer
Published Date
Dec 1, 2020
Volume
494
Pages
18 - 26
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.